As of Mar 19
| -0.79 / -2.38%|
The 9 analysts offering 12-month price forecasts for Medicines Co have a median target of 47.00, with a high estimate of 85.00 and a low estimate of 38.00. The median estimate represents a +45.06% increase from the last price of 32.40.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.